Vaccine Formulation Institute (VFI) and Desert King® (DK) have joined forces in a strategic alliance to revolutionize global access to vaccine adjuvants. This collaboration combines VFI’s open access philosophy and expertise in adjuvant formulation with DK’s world-leading sustainable production and purification of immunostimulating Quillaja saponins. Together, VFI and DK offer vaccine developers a licence-free access to a range of cost-effective liposomal and emulsion-based adjuvants incorporating saponins.
Read Press release here